Skip to main content

Juvenile arthritis

Treatment

01-10-2018 | Juvenile idiopathic arthritis | Review | Article

Glucocorticoid treatment in juvenile idiopathic arthritis

Batu ED. Rheumatol Int 2018. doi: 10.1007/s00296-018-4168-0

28-09-2018 | Juvenile idiopathic arthritis | Article

Juvenile arthritis management in less resourced countries (JAMLess): Consensus recommendations from the cradle of humankind

Scott C et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4304-y

21-08-2018 | Juvenile idiopathic arthritis | Article

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

Kearsley-Fleet L et al. Rheumatology (Oxford) 2018: key262. doi: 10.1093/rheumatology/key262

04-08-2018 | Biologics | Review | Article

A targeted literature review examining biologic therapy compliance and persistence in chronic inflammatory diseases to identify the associated unmet needs, driving factors, and consequences

Maniadakis N et al. Adv Ther 2018; 9: 1333–1355. doi: 10.1007/s12325-018-0759-0

12-07-2018 | Juvenile idiopathic arthritis | Article

Non-steroidal anti-inflammatory drug induces luteinized unruptured follicle syndrome in young female juvenile idiopathic arthritis patients

Tomioka RB et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4208-x

Group of children (symbolic image with models)

11-07-2018 | Pediatric | Review | Article

Pediatric Rheumatology Collaborative Study Group: Over four decades of pivotal clinical drug research in pediatric rheumatology

Brunner HI et al. Pediatr Rheumatol 2018; 16: 45. doi: 10.1186/s12969-018-0261-x

11-07-2018 | Juvenile idiopathic arthritis | Review | Article

Methotrexate in juvenile idiopathic arthritis: Advice and recommendations from the MARAJIA expert consensus meeting

Ferrara G et al. Pediatr Rheumatol 2018; 16: 46. doi: 10.1186/s12969-018-0255-8

01-07-2018 | Pregnancy | Article

Maternal and fetal outcomes in a cohort of patients exposed to tumor necrosis factor inhibitors throughout pregnancy

Genest G, Spitzer KA, Laskin CA. J Rheumatol 2018. doi: 10.3899/jrheum.171152

01-07-2018 | Juvenile idiopathic arthritis | Article

Growth during tocilizumab therapy for polyarticular-course juvenile idiopathic arthritis: 2-year data from a phase III clinical trial

Bharucha KN et al. J Rheumatol 2018. doi: 10.3899/jrheum.170326

28-06-2018 | Juvenile idiopathic arthritis | Article

Association of hand grip strength with disease activity, disability, and quality of life in children and adolescents with juvenile idiopathic arthritis

Rashed AM et al. Adv Rheumatol 2018; 58: 11. doi: 10.1186/s42358-018-0012-1

26-06-2018 | Juvenile idiopathic arthritis | Article

A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis

Lovell DJ et al. Pediatr Rheumatol 2018; 16: 41. doi: 10.1186/s12969-018-0260-y

08-06-2018 | Pain | Review | Article

Cannabinoids for the treatment of rheumatic diseases: Where do we stand?

Katz-Talmor D et al. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0025-5

06-06-2018 | Juvenile idiopathic arthritis | Review | Article

The emerging role of cardiovascular magnetic resonance imaging in the assessment of cardiac involvement in juvenile idiopathic arthritis

Mavrogeni S et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4078-1

05-06-2018 | Juvenile idiopathic arthritis | Article

A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q

Unal E et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4075-4

"Vitamin D" and vitamin D-rich foods

16-05-2018 | Juvenile idiopathic arthritis | Review | Article

Vitamin D and juvenile idiopathic arthritis

In this review, Finch et al summarize and evaluate the current literature relating to vitamin D and juvenile idiopathic arthritis.

Finch SL, Rosenberg AM, Vatanparast H. Pediatr Rheumatol 2018; 16: 34. doi: 10.1186/s12969-018-0250-0

03-05-2018 | Pain | Article

EULAR recommendations for the health professional’s approach to pain management in inflammatory arthritis and osteoarthritis

Geenen R et al. Ann Rheum Dis 2018; 77: 797–807. doi: 10.1136/annrheumdis-2017-212662

25-04-2018 | Juvenile idiopathic arthritis | Review | Article

Temporomandibular joint arthritis in juvenile idiopathic arthritis, now what?

Stoll ML et al. Pediatr Rheumatol 2018; 16: 32. doi: 10.1186/s12969-018-0244-y

15-04-2018 | Juvenile idiopathic arthritis | Article

Longterm safety and efficacy of adalimumab and infliximab for uveitis associated with juvenile idiopathic arthritis

Cecchin V et al. J Rheumatol 2018; Advance online publication. doi: 10.3899/jrheum.171006

13-04-2018 | Juvenile idiopathic arthritis | Article

Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial

Opoka-Winiarska V et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4071-9

11-04-2018 | Juvenile idiopathic arthritis | Article

Treating juvenile idiopathic arthritis to target: recommendations of an international task force

Ravelli A et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2018-213030